Vanguard Personalized Indexing Management
LGND icon

Vanguard Personalized Indexing Management’s Ligand Pharmaceuticals LGND Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$714K Buy
2,258
+96
+4% +$22.6K 0.01% 1184
2026
Q1 		$432K Buy
2,162
+771
+55% +$153K ﹤0.01% 1391
2025
Q4 		$263K Buy
1,391
+55
+4% +$10.6K ﹤0.01% 1587
2025
Q3 		$237K Buy
+1,336
New +$199K ﹤0.01% 1612

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Personalized Indexing Management's LGND Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Ligand Pharmaceuticals (LGND) stake by 4.4% in Q2 2026, buying an estimated $22.6K and bringing the position to 2,258 shares worth $714K. The position accounts for 0.01% of the portfolio, ranked #1184.

Vanguard Personalized Indexing Management first reported a position in LGND in Q3 2025 and has held it in 4 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Vanguard Personalized Indexing Management held 2,258 shares of Ligand Pharmaceuticals worth $714K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 96 Ligand Pharmaceuticals shares in Q2 2026, an estimated $22.6K.
  • Ligand Pharmaceuticals made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1184 holding.
  • Vanguard Personalized Indexing Management first reported a position in Ligand Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.